Pharmacovigilance in Psychiatry, 1st ed. 2016
Coordonnateurs : Spina Edoardo, Trifirò Gianluca
The first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance.
Internationally-recognised researchers, clinicians and pharmacovigilance experts contributed to this textbook, giving it the benefit of different perspectives and years of experience. Pharmacovigilance in psychiatry provides a thorough introduction to this field but goes on to explore advanced themes such as methodologies and resources used for pharmacovigilance in psychiatry, challenges as well as most recent developments to this field, making it suitable for under-graduates, graduate and post-doctoral students and persons working pharmacovigilance who seek to broaden their knowledge on this subject.1. Introduction: History of pharmacovigilance in psychiatry.- 2. Adverse drug reactions: definition and pathogenesis.- 3. Methodologies for pharmacovigilance monitoring of psychotropic drugs.- 4. The role of prescription event monitoring in pharmacovigilance of psychotropic drugs.- 5. The role of healthcare databases in pharmacovigilance of psychotropic drugs.- 6. Monitoring of plasma concentrations of psychotropic drugs in pharmacovigilance.- 7. The role of pharmacogenetics in pharmacovigilance of psychotropic drugs.- 8. Safety and tolerability of antidepressants.- 9. Safety and tolerability of antipsychotics.- 10. Safety and tolerability of anxiolytics/sedative hypnotics.- 11. Safety and tolerability of mood stabilizers.- 12. Safety and tolerability of medications for ADHD.- 13. Safety of psychotropic drugs in children and adolescents.- 14. Safety of psychotropic drugs in the elderly(Safety of psychotropic drugs in the elderly.- 15. Safety of psychotropic drugs in pregnancy and breastfeeding.
Edoardo Spina is Professor of Pharmacology at the Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. He is currently Head of the School of Specialisation in Pharmacology, co-ordinator of the PhD Course in Clinical and Experimental Neuropsychopharmacology and President of the Ethics Committee of the district area of Messina. His primary area of scientific interest is clinical neuropsychopharmacology, and has been involved in studies on the pharmacokinetics and drug interactions of CNS drugs, therapeutic drug monitoring, pharmacovigilance and pharmacoepidemiology of psychotropic drugs, and pharmacogenetics in psychiatry.
Gianluca Trifirò is Assistant Professor at the University of Messina and is honorary assistant professor at the Erasmus University Medical Center. In recent years, his main research activ
ities have been concernedwith the scientific coordination and management of multicentre, international projects (i.e. EU-ADR, ARITMO, Aritmo, SUCRE, SAFEGUARD, MPI-AGE) aimed at assessing post-marketing drug use and safety using multiple European electronic medical record databases.As well as authoring more than 100 scientific peer-reviewed scientific publications in international journals, he is a member of editorial boards and reviewer of several international journals in the area of pharmacovigilance and psychiatry. He is a member of the International Society of Pharmacoepidemiology (ISPE) and was co-chair of the ISPE 2011
First textbook to address the role of pharmacovigilance in psychiatry, providing readers with comprehensive information and insight on this topic
Discussions on the use of healthcare databases, pharmacogenetics and prescription event monitoring prepare readers for future developments in the field
Appeals to new and experienced readers by both covering foundations and exploring advanced topics
Date de parution : 03-2019
Ouvrage de 319 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 105,49 €
Ajouter au panierDate de parution : 12-2015
Ouvrage de 319 p.
15.5x23.5 cm
Thèmes de Pharmacovigilance in Psychiatry :
Mots-clés :
ADHD medications; Adverse Drug Reactions; Antidepressants; Antipsychotics; Anxiolytics/Sedative Hypnotics; Children and Adolescents; Elderly; Healthcare Databases; Methodologies; Mood Stabilizers; Pharmacogenetics; Plasma Concentration Monitoring; Pregnancy and Breastfeeding; Prescription Event Monitoring; psychopharmacology
